共 50 条
- [23] Age-and percent free PSA stratified risk analysis for prostate cancer detection in men with a total serum PSA 2-4ng/ml and benign digital rectal examination JOURNAL OF UROLOGY, 2004, 171 (04): : 332 - 332
- [25] Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0 ng./ml. JOURNAL OF UROLOGY, 2001, 165 (06): : 1930 - 1936
- [26] The clinical utility of measuring free-to-total prostate-specific antigen (PSA) ratio and PSA density in differentiating between benign prostatic hyperplasia and prostate cancer BRITISH JOURNAL OF UROLOGY, 1998, 81 (06): : 834 - 838
- [27] The clinical utility of measuring free-to-total prostate-specific antigen (PSA) ratio and PSA density in differentiating between benign prostatic hyperplasia and prostate cancer BRITISH JOURNAL OF UROLOGY, 1998, 82 (06): : 933 - 933
- [28] Influence of prostate volume and percent free prostate specific antigen on prostate cancer detection in men with a total prostate specific antigen of 2.6 to 10.0 ng/ml JOURNAL OF UROLOGY, 2007, 177 (05): : 1741 - 1744
- [30] Serum pro prostate specific antigen improves cancer detection compared to free and complexed prostate specific antigen in men with prostate specific antigen 2 to 4 ng/ml JOURNAL OF UROLOGY, 2003, 170 (06): : 2181 - 2185